The pricing provided is for single country selection. Multiple-country purchase discounts are available, please contact us.
Abstract
Product Description
Business Monitor International' s Pharmaceuticals and Healthcare Reports
provide industry professionals, market investors and corporate and
financial services analysts with independent forecasts and competitive
intelligence on pharmaceutical and healthcare industry.
Key Benefits of Report
- Benchmark BMI' s Independent 5-year Pharmaceutical and Healthcare
Industry Forecasts
- Target Business Opportunities & Risks in Pharmaceutical and Healthcare
Sector
- Exploit The Latest Competitive Pharmaceutical and Healthcare
Intelligence & company SWOTS
The pricing provided is for single country selection. Multiple-country purchase discounts are available, please contact us.
Table of Contents
Coverage
Executive Summary & Industry SWOT
An at-a-glance perspective on latest regulatory developments, key forecast
indicators and major corporate developments, covering the prescription, OTC
and generics markets. The SWOT outlines strategic factors which affect BMI' s
forecast analysis, and taken together with BMI' s Economic and Business
Environment SWOTS, give a complete overview of market climate.
Market Summary
Outline of market characteristics, growth factors, leading therapeutic
segments and a competitivness of the market.
Regulatory Regime
Guide to and analysis of country intellectual property developments and
pricing & reimbursement issues, which constitute the regulatory make-up of the
market.
Industry Developments
Focus on government healthcare reforms, epidemiological trends, company M&As,
product launches, market entries, FDI activity, R&D and patent legislation.
BMI 5-Year Industry Forecast
5-Year Forecasts for all key industry indicators (see list below), supported
by explicit assumptions, plus analysis of key downside risks to the main
forecast, including:
- Drug market expenditure (US$bn); drug expenditure per capita (US$); as %
of gdp
- Prescription drug market (US$bn)/as % of total market; sales by alimentary
tract/metabolism; antibiotics, cardiovascular, central nervous system,
oncology, musculoskeletal and respiratory system
- OTC market (US$bn)/as % of total market (sales by analgesic, cough and
cold, digestives, skin treatments, vitamins and minerals)
- Generics market (US$bn)/ as % of total market
- Health expenditure (US$bn, % of gdp and per capita); public sector health
expenditure as % of total; number of hospitals; beds, hospital admissions,
doctors, births and deaths per 000 population
Forecasts based on bespoke BMI economic modelling, using historical data sets
of macroeconomic and industry variables to derive rigorous statistical
relationships, anchored in advanced linear regression techniques.
BMI 5-Year Macroeconomic Forecasts
BMI forecasts for all headline macroeconomic indicators, including:
Nominal and real GDP, % real GDP growth, % private consumption growth, %
industrial output growth, % consumer price index, % GDP price deflator,
exports, imports, trade balance, current account balance, foreign direct
investment, exchange rate against US$, government expenditure, external debt
Competitive Landscape & Profiles
Intelligence on the market position of major MNC power houses and indigenous
companies. BMI profiles key research-based companies. Company SWOTS are
provided for all key strategic players, complete with a company activity
overview, its leading products and analysis of business opportunities.
